Richardson, K., Keam, S. P., Zhu, J. J., Meyran, D., D’Souza, C., Macdonald, S., Campbell, K., Robbins, M., Bezman, N. A., Todd, K., Quach, H., Ritchie, D. S., Harrison, S. J., Prince, H. M., Trapani, J. A., Jenkins, M. R., Beavis, P. A., Darcy, P. K. and Neeson, P. J. (2022) “The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells”, Haematologica. Pavia, Italy, 108(1), pp. 83-97. doi: 10.3324/haematol.2021.279930.